The Centers for Medicare & Medicaid Services (CMS) has made a change to the RITUXAN® (rituximab) J-code and has assigned a permanent J-code for RITUXAN HYCELA® (rituximab/hyaluronidase human subcutaneous injection). 
 
Effective January 1, 2019 J-code J9312 will replace J9310 for RITUXAN and the billable units will change from 100 mg to 10 mg. 
 
Additionally, the permanent J-code assigned for RITUXAN HYCELA is J9311 and the billable units will be 10 mg.
 
Click here to learn more.